FDA approves AstraZeneca's drug for rare form of blood cancer

The U.S. Food and Drug Administration said on Thursday it approved AstraZeneca Plc's treatment for hairy cell leukemia, a slow-growing type of blood cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news